VALD Pty Ltd

VALD Pty Ltd, based in Australia, specializes in musculoskeletal health technology, providing advanced tools that support health and performance professionals in making informed decisions. Founded in 2015 in Brisbane, Australia, VALD Pty Ltd focuses on enhancing musculoskeletal health through innovative technology solutions. The company has engaged in six funding deals, with the latest round occurring in September 2024, raising USD 25. 00 mn led by Vistara Growth and supported by investors including QIC.

The CEO, Laurie Malone, has a background in health technology, having previously worked at notable firms in the sector. VALD specializes in musculoskeletal health technology, offering a suite of products designed to enhance decision-making processes for health and performance professionals. Their core offerings include objective measurement tools, digital health systems, and proprietary datasets utilized in diverse environments such as elite sports, physical therapy clinics, hospitals, universities, and defense departments. VALD serves a broad client base of over 8,000 organizations, comprising more than 140,000 practitioners and over 2 million patients and athletes across 130 countries, including markets in North America, Europe, and Africa.

Their solutions cater to various disciplines, including strength and conditioning, physiotherapy, podiatry, and exercise physiology, ensuring comprehensive insights into musculoskeletal and neural performance. VALD generates revenue through a structured transaction model that includes subscriptions and partnerships with healthcare providers, sports teams, and educational institutions. Their offerings are typically sold through direct business-to-business (B2B) engagements, enabling seamless integration of technology into clients' existing workflows. VALD's products are offered in various pricing plans, aligned with their flagship solutions, which cater to the specific needs of different sectors within the musculoskeletal health industry.

Specific revenue figures and pricing for individual products or services are not publicly disclosed. In September 2024, VALD Pty Ltd raised USD 25. 00 mn in venture funding from new investor FTV Capital. The company plans to utilize this funding to expand its workforce internationally, introduce new product lines and functionalities, and apply AI to develop applications for its exclusive dataset of musculoskeletal medical records.